BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robe AJ, Kirby JA, Jones DE, Palmer JM. A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 2005;41:1106-12. [PMID: 15830397 DOI: 10.1002/hep.20642] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Jones DE. Pathogenesis of primary biliary cirrhosis. Clin Liver Dis. 2008;12:305-321; viii. [PMID: 18456182 DOI: 10.1016/j.cld.2008.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Djilali-Saiah I, Fakhfakh A, Louafi H, Caillat-Zucman S, Debray D, Alvarez F. HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis. J Hepatol. 2006;45:844-850. [PMID: 17050030 DOI: 10.1016/j.jhep.2006.07.034] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
3 Jones DE. Pathogenesis of primary biliary cirrhosis. Gut 2007;56:1615-24. [PMID: 17641080 DOI: 10.1136/gut.2007.122150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 40] [Article Influence: 1.1] [Reference Citation Analysis]
4 Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Gershwin ME. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 2007;45:314-22. [PMID: 17256753 DOI: 10.1002/hep.21522] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
5 Umeshappa CS, Singha S, Blanco J, Shao K, Nanjundappa RH, Yamanouchi J, Parés A, Serra P, Yang Y, Santamaria P. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nat Commun 2019;10:2150. [PMID: 31089130 DOI: 10.1038/s41467-019-09893-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
6 Charatcharoenwitthaya P, Lindor KD. Current concepts in the pathogenesis of primary biliary cirrhosis. Annals of Hepatology 2005;4:161-75. [DOI: 10.1016/s1665-2681(19)32061-7] [Cited by in Crossref: 12] [Article Influence: 0.7] [Reference Citation Analysis]
7 Lee J, Choi TG, Ha J, Kim SS. Cyclosporine A suppresses immunoglobulin G biosynthesis via inhibition of cyclophilin B in murine hybridomas and B cells. Int Immunopharmacol 2012;12:42-9. [PMID: 22032839 DOI: 10.1016/j.intimp.2011.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
8 Wang C, Shi Y, Wang X, Ma H, Liu Q, Gao Y, Niu J. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Front Immunol 2022;13:940688. [DOI: 10.3389/fimmu.2022.940688] [Reference Citation Analysis]
9 Sutti S, Vidali M, Mombello C, Sartori M, Albano E. Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C. J Viral Hepat. 2010;17:685-690. [PMID: 20738774 DOI: 10.1111/j.1365-2893.2010.01359.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
10 Khanna A, Jones DE. Novel strategies and therapeutic options for the management of primary biliary cholangitis. Therap Adv Gastroenterol 2017;10:791-803. [PMID: 29051789 DOI: 10.1177/1756283X17728669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Marin JJ, Bujanda L, Banales JM. MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol. 2014;30:303-309 [PMID: 24553410 DOI: 10.1097/MOG.0000000000000051]3 Zhang L, Ma D, Li X, Deng C, Shi Q, You X, Leng X, Li M, Tang F, Zhang F, Li Y. Gene expression profiles of peripheral blood mononuclear cells in primary biliary cirrhosis. Clin Exp Med 2014; 14: 409-416. [PMID: 23958878 DOI: 10.1007/s10238-013-0253-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Rutherford AE, Pratt DS. Cholestasis and cholestatic syndromes. Curr Opin Gastroenterol. 2006;22:209-214. [PMID: 16550034 DOI: 10.1097/01.mog.0000218956.63311.47] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]